Contract 75N93024C00073
Tetracore, Inc. · Department Of Health And Human Services · September 3, 2024
Tetracore, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 3, 2024 for $1.49 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Rockville, MD. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing.
Contract details
- PIID
- 75N93024C00073
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Rockville, MD
- First action
- September 3, 2024
Description
PHASE II DEVELOPMENT OF RAPID MOLECULAR ASSAY FOR POINT OF CARE DETECTION OF TREPONEMA PALLIDUM
Modification timeline
-
September 3, 2024Base award$1.49M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93024C00073?
Contract 75N93024C00073 is a federal contract awarded to Tetracore, Inc. by Department Of Health And Human Services on September 3, 2024 for $1.49 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N93024C00073?
Tetracore, Inc. won contract 75N93024C00073 from Department Of Health And Human Services.
How much is contract 75N93024C00073 worth?
Contract 75N93024C00073 has obligated $1.49 million to date.